Mounjaro (tirzepatide) is a weekly injectable medication that works by activating two gut hormone receptors, GLP-1 and GIP, to improve weight management in individuals with obesity or who are overweight with weight-related health problems.
Mounjaro demonstrates significant weight loss in clinical trials (up to 22%) by suppressing appetite and promoting feelings of fullness.
Wegovy (semaglutide) is a weekly injectable medication that works by mimicking a natural gut hormone called GLP-1, to allow chronic weight management in those with obesity or who are overweight with weight-related medical conditions.
Clinical trials demonstrate Wegovy promotes up to 15% weight loss by increasing feelings of fullness, reducing hunger, and slowing down stomach emptying.
Orlistat is an oral medication, taken up to three times a day, used for weight loss and weight management. It works by reversibly inhibiting gastric and pancreatic lipases, enzymes in your digestive system that break down dietary fats.
By blocking these enzymes, Orlistat prevents about 25-30% of the fat you eat from being absorbed by your body. Studies suggest individuals on Orlistat experience 5-10% weight loss closely linked to managing dietary fat intake.
See if you are eligible! Read More
Please enter your height and weight to get your result
Your BMI suggests you’re .
Your ideal weight is between
